Abstract
The world, today, is facing an immense challenge with the outbreak of severe acute respiratorysyndrome coronavirus 2 (SARS-CoV-2) infection known as coronavirus disease 2019(COVID-19). We soughtto investigate the effectiveness of ivermectin plus doxycycline in COVID-19-positive cancerpatients in a tertiary care cancer center of Dhaka city in Bangladesh.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Molecular and Immuno Oncology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
